Vestcor Inc Has $721,000 Stake in Maximus, Inc. (NYSE:MMS)

Vestcor Inc trimmed its holdings in shares of Maximus, Inc. (NYSE:MMS) by 43.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,654 shares of the health services provider’s stock after selling 7,543 shares during the period. Vestcor Inc’s holdings in Maximus were worth $721,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Avantax Advisory Services Inc. increased its holdings in Maximus by 4.8% during the 4th quarter. Avantax Advisory Services Inc. now owns 19,097 shares of the health services provider’s stock valued at $1,426,000 after purchasing an additional 869 shares in the last quarter. Farther Finance Advisors LLC increased its stake in shares of Maximus by 109.2% in the 4th quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider’s stock valued at $61,000 after buying an additional 428 shares during the period. Inspire Advisors LLC increased its stake in shares of Maximus by 3.1% in the 4th quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider’s stock valued at $646,000 after buying an additional 258 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Maximus by 19.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,413 shares of the health services provider’s stock valued at $1,151,000 after buying an additional 2,464 shares during the period. Finally, Ruffer LLP acquired a new stake in shares of Maximus in the 4th quarter valued at $10,266,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on MMS shares. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a research note on Thursday, January 2nd. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th.

Insiders Place Their Bets

In other news, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the sale, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Bruce Caswell purchased 3,500 shares of the business’s stock in a transaction dated Tuesday, December 17th. The stock was purchased at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the acquisition, the chief executive officer now owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This represents a 1.28 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.60% of the company’s stock.

Maximus Stock Up 0.3 %

NYSE:MMS opened at $67.06 on Monday. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm has a market capitalization of $3.80 billion, a P/E ratio of 14.42 and a beta of 0.71. The stock’s fifty day simple moving average is $72.01 and its 200-day simple moving average is $79.30.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Equities research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.79%. Maximus’s dividend payout ratio is presently 25.81%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.